Seelos Therapeutics Announces Completion of Open-Label Patient Enrollment of Proof of Concept Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
Silo Wellness Commences Trading on the Canadian Securities Exchange Under Ticker Symbol "SILO" Psychedelics Investing
REPEAT - Hollister Biosciences Inc. Announces closing of $7.9M Private Placement of Special Warrants, Including Full Exercise of Agents' Option Psychedelics Investing
Regulatory approvals place Numinus lab at the forefront of global psychedelics research Cannabis Investing News
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board Cannabis Investing News
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development Cannabis Investing News
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company Psychedelics Investing
Hollister Biosciences Inc. Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2020. Psychedelics Investing
